Banque Pictet & Cie SA cut its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 26.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,829 shares of the financial services provider’s stock after selling 25,350 shares during the period. Banque Pictet & Cie SA’s holdings in iShares Nasdaq Biotechnology ETF were worth $6,734,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pictet North America Advisors SA bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter worth approximately $231,000. Hayden Royal LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter worth approximately $202,000. Alpha Cubed Investments LLC raised its stake in shares of iShares Nasdaq Biotechnology ETF by 3.0% during the fourth quarter. Alpha Cubed Investments LLC now owns 45,920 shares of the financial services provider’s stock worth $4,428,000 after buying an additional 1,324 shares during the last quarter. Rothschild Capital Partners LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter worth approximately $1,785,000. Finally, CAPROCK Group Inc. raised its stake in shares of iShares Nasdaq Biotechnology ETF by 16.6% during the fourth quarter. CAPROCK Group Inc. now owns 33,908 shares of the financial services provider’s stock worth $3,270,000 after buying an additional 4,832 shares during the last quarter. 66.16% of the stock is owned by institutional investors.

IBB opened at $110.36 on Friday. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $89.01 and a fifty-two week high of $122.97.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2019/02/02/ishares-nasdaq-biotechnology-etf-ibb-shares-sold-by-banque-pictet-cie-sa.html.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: Discount Rate

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.